<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Greco F</submitter><funding>Istituto Pasteur—Fondazione Cenci Bolognetti to Valerio Fulci</funding><funding>Ministry of Health</funding><funding>Ministry of Health “Ricerca Corrente 2023”</funding><funding>istituto Pasteur Italia - Fondazione Cenci Bolognetti</funding><pagination>33</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10301948</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(3)</volume><pubmed_abstract>Virus-encoded microRNAs were first reported in the Epstein-Barr virus in 2004. Subsequently, a few hundred viral miRNAs have been identified, mainly in DNA viruses belonging to the &lt;i>herpesviridae&lt;/i> family. To date, only 30 viral miRNAs encoded by RNA viruses are reported by miRBase. Since the outbreak of the SARS-CoV-2 pandemic, several studies have predicted and, in some cases, experimentally validated miRNAs originating from the positive strand of the SARS-CoV-2 genome. By integrating NGS data analysis and qRT-PCR approaches, we found that SARS-CoV-2 also encodes for a viral miRNA arising from the minus (antisense) strand of the viral genome, in the region encoding for ORF1ab, herein referred to as SARS-CoV-2-miR-AS1. Our data show that the expression of this microRNA increases in a </pubmed_abstract><journal>Non-coding RNA</journal><pubmed_title>A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity.</pubmed_title><pmcid>PMC10301948</pmcid><funding_grant_id>Ricerca Corrente 2023</funding_grant_id><funding_grant_id>Call “under 45”—2020</funding_grant_id><funding_grant_id>under 45 2020</funding_grant_id><pubmed_authors>Ciccosanti F</pubmed_authors><pubmed_authors>Di Rienzo M</pubmed_authors><pubmed_authors>Fimia GM</pubmed_authors><pubmed_authors>Fulci V</pubmed_authors><pubmed_authors>Lorefice E</pubmed_authors><pubmed_authors>Laudadio I</pubmed_authors><pubmed_authors>Maggi F</pubmed_authors><pubmed_authors>Carissimi C</pubmed_authors><pubmed_authors>Greco F</pubmed_authors><pubmed_authors>Meschi S</pubmed_authors><pubmed_authors>Colavita F</pubmed_authors></additional><is_claimable>false</is_claimable><name>A microRNA Arising from the Negative Strand of SARS-CoV-2 Genome Targets FOS to Reduce AP-1 Activity.</name><description>Virus-encoded microRNAs were first reported in the Epstein-Barr virus in 2004. Subsequently, a few hundred viral miRNAs have been identified, mainly in DNA viruses belonging to the &lt;i>herpesviridae&lt;/i> family. To date, only 30 viral miRNAs encoded by RNA viruses are reported by miRBase. Since the outbreak of the SARS-CoV-2 pandemic, several studies have predicted and, in some cases, experimentally validated miRNAs originating from the positive strand of the SARS-CoV-2 genome. By integrating NGS data analysis and qRT-PCR approaches, we found that SARS-CoV-2 also encodes for a viral miRNA arising from the minus (antisense) strand of the viral genome, in the region encoding for ORF1ab, herein referred to as SARS-CoV-2-miR-AS1. Our data show that the expression of this microRNA increases in a </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2026-04-08T14:08:47.762Z</modification><creation>2025-04-04T20:28:32.951Z</creation></dates><accession>S-EPMC10301948</accession><cross_references><pubmed>37368333</pubmed><doi>10.3390/ncrna9030033</doi></cross_references></HashMap>